Fidelity International’s Tempest Therapeutics TPST Stock Holding History

Fidelity International’s Portfolio TPST Stock Details TPST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9,968	Closed	-$108K	–	964
2024 Q4	$108K	Hold	9,968	–	–	﹤0.01%	836
2024 Q3	$181K	Hold	9,968	–	–	﹤0.01%	829
2024 Q2	$284K	Hold	9,968	–	–	﹤0.01%	783
2024 Q1	$507K	Hold	9,968	–	–	﹤0.01%	759
2023 Q4	$570K	Hold	9,968	–	–	﹤0.01%	730
2023 Q3	$40.6K	Hold	9,968	–	–	﹤0.01%	747
2023 Q2	$165K	Hold	9,968	–	–	﹤0.01%	736
2023 Q1	$301K	Hold	9,968	–	–	﹤0.01%	747
2022 Q4	$150K	Hold	9,968	–	–	﹤0.01%	777
2022 Q3	$225K	Hold	9,968	–	–	﹤0.01%	762
2022 Q2	$275K	Hold	9,968	–	–	﹤0.01%	763
2022 Q1	$441K	Hold	9,968	–	–	﹤0.01%	764
2021 Q4	$684K	Hold	9,968	–	–	﹤0.01%	752
2021 Q3	$1.88M	Hold	9,968	–	–	﹤0.01%	677
2021 Q2	$1.45M	Buy	+9,968	New	+$2.24M	﹤0.01%	722
2016 Q1	–	Sell	-57	Closed	-$1.62M	–	515
2015 Q4	$1.62M	Hold	57	–	–	﹤0.01%	445
2015 Q3	$1.41M	Hold	57	–	–	﹤0.01%	461
2015 Q2	$4.8M	Buy	57 +1	+2%	+$91.6K	0.02%	419
2015 Q1	$5.69M	Buy	56 +29	+107%	+$3.86M	0.02%	406
2014 Q4	$3.48M	Buy	+27	New	+$1.98M	0.01%	426

Other funds holding TPST

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity International's TPST Position: Q1 2025 in Review

Fidelity International sold out of Tempest Therapeutics (TPST) in Q1 2025, closing a stake of 9,968 shares — an estimated $108K sold.

Fidelity International first reported a position in TPST in Q4 2014 and held it in 20 quarters. The position peaked at $5.69M in Q1 2015. 23 funds tracked by Wall St. Rank hold TPST as of Q1 2025.

Fidelity International reported no remaining Tempest Therapeutics position as of Q1 2025 after selling out during the quarter.
Fidelity International sold 9,968 Tempest Therapeutics shares in Q1 2025, an estimated $108K.
Fidelity International first reported a position in Tempest Therapeutics in Q4 2014 and held it in 20 quarters.
Fidelity International's Tempest Therapeutics position peaked at $5.69M in Q1 2015.
23 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q1 2025.

Based on Fidelity International's 13F filing for Q1 2025, filed 12 May 2025.